Search

Author/Creator Forer, David

1. Clinical outcomes and survival surrogacy studies of prostate‐specific antigen declines following enzalutamide in men with metastatic castration‐resistant prostate cancer previously treated with docetaxel. Issue 12 (7th February 2017)

Authors:
Armstrong, Andrew J.; Saad, Fred; Phung, De; Dmuchowski, Carl; Shore, Neal D.; Fizazi, Karim; Hirmand, Mohammad; Forer, David; Scher, Howard I.; Bono, Johann De
Journal:
Cancer
Issue:
Volume 123:Issue 12(2017)
Page Start:
2303
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research. (December 2016)

Authors:
Penson, David F; Lin, Daniel W; Karsh, Lawrence; Quinn, David I; Shevrin, Daniel H; Shore, Neal; Symanowski, James T; Brown, Bruce; Forer, David; Wong, Elaine K; Flanders, Scott C
Journal:
Future oncology
Issue:
Volume 12:Number 23(2016)
Page Start:
2689
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search